Name Net closed
positions
Closed positions New positions Return since
30 Sep ‘17
26
8 12 4 99.9%
27
8 11 3 47.4%
28
7 39 32 94%
OSG
29
Octave Specialty Group
OSG
$206M
7 19 12 73.5%
30
7 16 9 94.1%
31
7 13 6 85.3%
32
7 12 5 82.7%
33
7 11 4 57.7%
34
7 11 4 22.2%
35
7 9 2 78.4%
BBC icon
36
Virtus Biotech Clinical Trials ETF
BBC
$37.8M
7 8 1 61.9%
37
6 20 14 94.4%
38
6 20 14 54.8%
39
6 12 6 17.9%
40
6 12 6 90.8%
41
6 11 5 100%
42
6 11 5 19.5%
43
6 10 4 74.3%
44
6 10 4 24.6%
45
6 10 4 98.7%
46
6 10 4 117%
47
6 10 4 60.6%
48
6 9 3 52.5%
49
6 9 3 33.9%
50
6 9 3 47.7%